
Study Confirms Women More Likely To Endure Liver Damage From Binge Drinking
Krystina Murray ❘
Women, who metabolize alcohol differently than men, may want to avoid binge drinking after learning its effects.
Read More ⟶
Take the first step towards recovery
by Ginni Correa | ❘
The creators of Dsuvia, a new opioid 10 times stronger than fentanyl, have claimed it will save lives, but many critics believe it should not have been approved in the first place. The drug was initially funded by the Defense Department in 2015 and despite much opposition, it was finally approved by the FDA in 2018. Six months after the approval, an FBI intelligence bulletin marked “for official use only,” warned that the new drug would worsen the nation’s opioid epidemic. As efforts have focused on cracking down on opioid abuse and limiting production over the past years, hospitals are now seeing shortages of some opioids needed to intubate patients affected by COVID-19. Despite the initial setbacks on approving the drug, some now call it a life saver in a time that patients are in need of effective pain management.
Dsuvia is the brand name for the pill form of the synthetic opioid, sufentanil. It’s only available in a single dosage as a small pill meant to dissolve under the tongue. Due to its potency, Dsuvia is only meant to be administered by a healthcare provider in a medically supervised setting. It is considered 5 to 10 times stronger than fentanyl, a drug that is associated with many overdose deaths, and 500 to 1,000 times more powerful than morphine. The development and approval of Dsuvia are in large part the result of interest from the Department of Defense, which initially funded the drug. Dsuvia is the result of years of collaboration between the creators and the Pentagon.
Online Addiction Counseling
Get professional help from an online addiction and mental health counselor from BetterHelp.
Start receiving support via phone, video, or live-chat.
Paid Advertising. We may receive advertising fees if you follow links to the BetterHelp site.
The development and approval of Dsuvia may be considered essential by those who believe it has the potential to save lives, especially during the current pandemic. Despite the increase in illicit opioid use in the recent years, hospitals are experiencing a shortage in the drugs necessary to intubate patients affected by COVID-19. The creators of Dsuvia believe the drug, which was initially created for use on the battlefield, can be just as effective in treating hospital patients.
Last Edited:
Ginni Correa
Ginni Correa is a Latinx writer and activist living in Orlando,FL. She earned her bachelor’s degree from the University of Central Florida and double majored in Psychology and Spanish with a minor in Latin American Studies. After graduation, Ginni worked as an educator in public schools and an art therapist in a behavioral health hospital where she found a passion working with at-risk populations and advocating for social justice and equality. She is also experienced in translating and interpreting with an emphasis in language justice and creating multilingual spaces. Ginni’s mission is to build awareness and promote resources that can help people transform their lives. She believes in the importance of ending stigma surrounding mental health and substance abuse while creating more accessible treatment in communities. In her spare time, she enjoys reading, crafting, and attending music festivals.
Sources
Recovery Starts Today
Call Now For Addiction Support